Figure 2From: RIZ1 is potential CML tumor suppressor that is down-regulated during disease progressionRIZ1 expression in G-CSF mobilized peripheral blood. Flow cytometry analysis of RIZ1 protein expression in granulocytes, monocytes, and CD34+ cells. (Con) represents flow cytometry analysis in the absence of the RIZ1 primary antibody.Back to article page